{
    "organizations": [],
    "uuid": "bad37ccc148297c3e222f66f7250b05c7bce4129",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/03/07/the-associated-press-regulus-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Regulus reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Wednesday reported a loss of $14.4 million in its fourth quarter.\nThe San Diego-based company said it had a loss of 14 cents per share.\nThe results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.\nThe biopharmaceutical company posted revenue of $18,000 in the period.\nFor the year, the company reported that its loss narrowed to $71.9 million, or 96 cents per share. Revenue was reported as $72,000.\nIn the final minutes of trading on Wednesday, the company's shares hit $1.26. A year ago, they were trading at $1.15.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS",
    "published": "2018-03-07T23:31:00.000+02:00",
    "crawled": "2018-03-08T00:11:35.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "san",
        "diego",
        "ap",
        "regulus",
        "therapeutic",
        "rgls",
        "wednesday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "san",
        "company",
        "said",
        "loss",
        "cent",
        "per",
        "share",
        "result",
        "exceeded",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "four",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "biopharmaceutical",
        "company",
        "posted",
        "revenue",
        "period",
        "year",
        "company",
        "reported",
        "loss",
        "narrowed",
        "million",
        "cent",
        "per",
        "share",
        "revenue",
        "reported",
        "final",
        "minute",
        "trading",
        "wednesday",
        "company",
        "share",
        "hit",
        "year",
        "ago",
        "trading",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "rgls",
        "http"
    ]
}